Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 141,902 shares at $30.65 ($4.3M) on 2016-06-01, disclosed to the SEC on 2016-06-02.
Open-market sale of $4.3M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.12 | 18,510 | $558K | 12.9% |
| 2 | $30.12 | 18,510 | $558K | 12.9% |
| 3 | $30.65 | 52,441 | $1.6M | 37.1% |
| 4 | $30.65 | 52,441 | $1.6M | 37.1% |
| Total | $30.51 avg | 141,902 | $4.3M | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |